Related references
Note: Only part of the references are listed.Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor
Shin-ichiro Yoshizawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV
Jared S. Morse et al.
CHEMBIOCHEM (2020)
Structure-Based Stabilization of Non-native Protein-Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design
Shan-Meng Lin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
SARS-CoV-2 is an appropriate name for the new coronavirus
Yuntao Wu et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Abdo A. Elfiky
LIFE SCIENCES (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
Zahra Sahraei et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Risk Factors for Fatal Middle East Respiratory Syndrome Coronavirus Infections in Saudi Arabia: Analysis of the WHO Line List, 2013-2018
Arifur Rahman et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV
Abdo A. Elfiky et al.
LIFE SCIENCES (2019)
Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines
April M. Jorge et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Molecular Evolution of Human Coronavirus Genomes
Diego Forni et al.
TRENDS IN MICROBIOLOGY (2017)
X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design
Jozlyn R. Clasman et al.
SCIENTIFIC REPORTS (2017)
Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors
Vathan Kumar et al.
ANTIVIRAL RESEARCH (2017)
Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV
Ji-Young Park et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein
Chung-ke Chang et al.
DRUG DISCOVERY TODAY (2016)
Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials
Abdo A. Elfiky
JOURNAL OF MEDICAL VIROLOGY (2016)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens
Nicole R. Sexton et al.
JOURNAL OF VIROLOGY (2016)
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion
Christopher M. Coleman et al.
JOURNAL OF VIROLOGY (2016)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
Tomonari Muramatsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV
Hyun Lee et al.
ACS CHEMICAL BIOLOGY (2015)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
Yahira M. Baez-Santos et al.
ANTIVIRAL RESEARCH (2015)
Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus
Kai-Wen Cheng et al.
ANTIVIRAL RESEARCH (2015)
Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
Yasuhiro Shimamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4-The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS)
Sarah E. St John et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design
Sarah E. St. John et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro) IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS
Sakshi Tomar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Middle East respiratory syndrome
Alimuddin Zumla et al.
LANCET (2015)
SOUTH KOREA MERS cases spotlight lack of research
Declan Butler
NATURE (2015)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features
Jian Lei et al.
ANTIVIRAL RESEARCH (2014)
Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings
Hyun Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors
Wei Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Crystal Structure of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Papain-like Protease Bound to Ubiquitin Facilitates Targeted Disruption of Deubiquitinating Activity to Demonstrate Its Role in Innate Immune Suppression
Ben A. Bailey-Elkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases
Yahira M. Baez-Santos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Coronaviruses Resistant to a 3C-Like Protease Inhibitor Are Attenuated for Replication and Pathogenesis, Revealing a Low Genetic Barrier but High Fitness Cost of Resistance
Xufang Deng et al.
JOURNAL OF VIROLOGY (2014)
Catalytic Function and Substrate Specificity of the Papain-Like Protease Domain of nsp3 from the Middle East Respiratory Syndrome Coronavirus
Yahira M. Baez-Santos et al.
JOURNAL OF VIROLOGY (2014)
Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease
Kiira Ratia et al.
PLOS PATHOGENS (2014)
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
Rolf Hilgenfeld et al.
ANTIVIRAL RESEARCH (2013)
Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
Sho Konno et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa
Jung Keun Cho et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding
Mark Turlington et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure-activity relationship study
Pillaiyar Thanigaimalai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
Pillaiyar Thanigaimalai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Anti-SARS coronavirus agents: a patent review (2008-present)
Vathan Kumar et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
Jon Jacobs et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms
Adeyemi O. Adedeji et al.
JOURNAL OF VIROLOGY (2013)
Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections
Ziad A. Memish et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection
Isabella Eckerle et al.
VIROLOGY JOURNAL (2013)
Severe Acute Respiratory Syndrome Coronavirus Nonstructural Proteins 3, 4, and 6 Induce Double-Membrane Vesicles
Megan M. Angelini et al.
MBIO (2013)
The role of UBL domains in ubiquitin-specific proteases
Alex C. Faesen et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Diarylheptanoids from Alnus japonica Inhibit Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus
Ji-Young Park et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
Ji-Young Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
Miyuki Kawase et al.
JOURNAL OF VIROLOGY (2012)
Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
Lili Zhu et al.
ANTIVIRAL RESEARCH (2011)
Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery
R. Ramajayam et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation
Thi Thanh Hanh Nguyen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors
Kenichi Akaji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Yeast Based Small Molecule Screen for Inhibitors of SARS-CoV
Matthew Frieman et al.
PLOS ONE (2011)
Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition
Young Bae Ryu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors
R. Ramajayam et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease
R. Ramajayam et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii
Young Bae Ryu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Severe Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein-Ligand X-ray Structure and Biological Evaluation
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CLpro inhibitors
Thomas Regnier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level
Konrad Stadler et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
Chi-Yuan Chou et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV M-pro
Chunying Niu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits
Prasenjit Mukherjee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors
Arun K. Ghosh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3
Benjamin W. Neuman et al.
JOURNAL OF VIROLOGY (2008)
A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
Kiira Ratia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
SARS coronavirus replicase proteins in pathogenesis
Rachel L. Graham et al.
VIRUS RESEARCH (2008)
Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery
Valerie Grum-Tokars et al.
VIRUS RESEARCH (2008)
The SARS-coronavirus PLnc domain of nsp3 as a replication/transcription scaffolding protein
Isabelle Imberta et al.
VIRUS RESEARCH (2008)
The SARS-unique domain (SUD) of SARS coronavirus is an oligo(G)-binding protein
Jinzhi Tan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus
Pedro Serrano et al.
JOURNAL OF VIROLOGY (2007)
Structure-based design,synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors
Arun K. Ghosh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors
Yi-Ming Shao et al.
CHEMBIOCHEM (2007)
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus
Chih-Chun Wen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Membrane topology of murine coronavirus replicase nonstructural protein 3
Amornrat Kanjanahaluethai et al.
VIROLOGY (2007)
Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters
Jianmin Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Identification of new human coronaviruses
Krzysztof Pyrc et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains
Marie-Pierre Egloff et al.
JOURNAL OF VIROLOGY (2006)
Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor
Syaulan Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors
Lu Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies
Keng-Chang Tsai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Enzymatic activity of the SARS coronavirus main proteinase dimer
Vito Graziano et al.
FEBS LETTERS (2006)
Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzyme
K Ratia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease
CY Wu et al.
CHEMISTRY & BIOLOGY (2006)
Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors
HZ Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Targeting proteases: successes, failures and future prospects
Boris Turk
NATURE REVIEWS DRUG DISCOVERY (2006)
Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide
TW Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors
AK Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1-phosphate dephosphorylation by a conserved domain of nsP3
KS Saikatendu et al.
STRUCTURE (2005)
Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic α,β-unsaturated esters
JJ Shie et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease
JJ Shie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors
LR Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro
LL Chen et al.
JOURNAL OF VIROLOGY (2005)
Antiviral activity of glycyrrhizic acid derivatives against SARS - Coronavirus
G Hoever et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Programmed ribosomal frameshifting in decoding the SARS-CoV genome
PV Baranov et al.
VIROLOGY (2005)
Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus
S Åkerström et al.
JOURNAL OF VIROLOGY (2005)
Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
B Morgenstern et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3)
CN Chen et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase
ZM Liu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
Severe acute respiratory syndrome related coronavirus is inhibited by interferon-α
U Ströher et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase
KQ Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics
RY Kao et al.
CHEMISTRY & BIOLOGY (2004)
Teaching old drugs to kill new bugs: structure-based discovery of anti-SARS drugs
RV Rajnarayanan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro
RP Jain et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Small molecules targeting severe acute respiratory syndrome human coronavirus
CY Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide
CJ Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Severe acute respiratory syndrome
JSM Peiris et al.
NATURE MEDICINE (2004)
Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity
BH Harcourt et al.
JOURNAL OF VIROLOGY (2004)
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate
CJ Kuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme - Defining the extra domain as a new target for design of highly specific protease inhibitors
JH Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
N Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay
RY Kao et al.
FEBS LETTERS (2004)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells
L Yi et al.
JOURNAL OF VIROLOGY (2004)
Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs
XW Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
JE Blanchard et al.
CHEMISTRY & BIOLOGY (2004)
Severe acute respiratory syndrome
MD Christian et al.
CLINICAL INFECTIOUS DISEASES (2004)
Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro
U Bacha et al.
BIOCHEMISTRY (2004)
Molecular model of SARS coronavirus polymerase: Implications for biochemical functions and drug design
X Xu et al.
NUCLEIC ACIDS RESEARCH (2003)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
HT Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mechanisms and enzymes involved in SARS coronavirus genome expression
V Thiel et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage
EJ Snijder et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
J Cinatl et al.
LANCET (2003)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Aza-peptide epoxides: A new class of inhibitors selective for clan CD cysteine proteases
JL Asgian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain
K Anand et al.
EMBO JOURNAL (2002)
Comparison of genomic and predicted amino acid sequences of respiratory and enteric bovine coronaviruses isolated from the same animal with fatal shipping pneumonia
VN Chouljenko et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Virus-encoded proteinases and proteolytic processing in the Nidovirales
J Ziebuhr et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Share Paper
